73391-97-6

Upstream product

• 598-21-0 2-Bromoacetyl bromide 
• 589-08-2 N-Methyl-N-phenethylamine 

Downstream Products

• 141834-87-9 N-methyl-N-phenethyl-2-[(5-benzyloxy-3-formyl)indol-1-yl]acetamide 
• 141834-88-0 N-methyl-N-phenethyl-2-[(6-benzyloxy-3-formyl)indol-1-yl]acetamide 
• 180512-84-9 5-benzyloxy-4-methoxymethyl-9-{2-[N-methyl-N-(2-phenylethyl)-amino]-2-oxoethyl}-9H-pyrido[3,4-b]indole-3-carboxylic acid-(1-methylethyl)-ester 
• 142588-36-1 3-benzyloxy-5-[(N-methyl-N-phenethyl)carbamoylmethoxy]-1-[(N-methyl-N-phenethyl)carbamoylmethyl]benzene 
• 141835-63-4 N-methyl-N-phenethyl-2-[(4-benzyloxy-3-formyl)indol-1-yl]acetamide 
• 173844-20-7 2-[1-{4-Benzyloxy-1-[(methyl-phenethyl-carbamoyl)-methyl]-1H-indol-3-yl}-meth-(E)-ylidene]-butyric acid ethyl ester 
• 141834-99-3 (E)-3-{6-Benzyloxy-1-[(methyl-phenethyl-carbamoyl)-methyl]-1H-indol-3-yl}-acrylic acid ethyl ester 
• 141863-33-4 (2E,4E)-5-{5-Benzyloxy-1-[(methyl-phenethyl-carbamoyl)-methyl]-1H-indol-3-yl}-penta-2,4-dienoic acid ethyl ester 
• 141835-06-5 2-[1-{5-Benzyloxy-1-[(methyl-phenethyl-carbamoyl)-methyl]-1H-indol-3-yl}-meth-(E)-ylidene]-butyric acid ethyl ester 
• 181258-79-7 (E)-3-{4-Benzyloxy-1-[(methyl-phenethyl-carbamoyl)-methyl]-1H-indol-3-yl}-2-methyl-acrylic acid ethyl ester 
• 141835-01-0 (E)-3-{7-Benzyloxy-1-[(methyl-phenethyl-carbamoyl)-methyl]-1H-indol-3-yl}-acrylic acid ethyl ester 
• 141835-00-9 (E)-3-{4-Benzyloxy-1-[(methyl-phenethyl-carbamoyl)-methyl]-1H-indol-3-yl}-acrylic acid ethyl ester 
• 141834-97-1 N-methyl-N-phenethyl-2[-5-benzyloxy-3-(2-carbethoxyethyl)indol-1-yl]acetamide 

Relevant academic research and scientific papers

Synthesis of γ-lactams via Ru(II)–Pheox-catalyzed regioselective intramolecular Csp3–H insertion of diazoacetamides

Herein, γ-lactam derivatives are obtained in high yield via highly regioselective intramolecular Csp3–H insertion reactions of α-diazoacetamides catalyzed by a rac-Ru(II)–Pheox complex. The catalytic system is applicable to a wide range of diaz

9H-Pyridu ((3,4-b) indole derivatives

9H-Pyrido?3,4-b!indole compounds have a pronounced leukotriene-B4 antagonistic action, and thus show a completely different spectrum of activity than known β-carbolines.

Structure-activity relationships study of two series of leukotriene B4 antagonists: Novel indolyl and naphthyl compounds substituted with a 2- [methyl(2-phenethyl)amino]-2-oxoethyl side chain

N-Methyl-N-phenethylphenylacetamide has been reported to be a key binding domain to LTB4 receptors. Here we describe the synthesis and structure-activity relationship (SAR) studies of two new series of LTB4 receptor antagonists in wh

SUBSTITUTED MONOCYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY

Monocyclic aryl compounds having selective LTB 4 antagonists properties and comprising an amido substituent, a substituent group having a terminal carboxylic acid or derivative thereof and a lipophilic substituent, therapeutic compositions and methods of treatment of disorders which result from LTB. sub.4 activity using the monocyclic aryl compounds are disclosed.